![Gregory Lambrecht](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gregory Lambrecht
Gründer bei Intrinsic Therapeutics, Inc.
Aktive Positionen von Gregory Lambrecht
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Intrinsic Therapeutics, Inc.
![]() Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Direktor/Vorstandsmitglied | 01.01.1999 | - |
Gründer | 01.01.1999 | - | |
Coravin, Inc.
![]() Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Vorsitzender | - | - |
Gründer | - | - |
Karriereverlauf von Gregory Lambrecht
Ehemalige bekannte Positionen von Gregory Lambrecht
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Viacor, Inc.
![]() Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Direktor/Vorstandsmitglied | - | 04.04.2012 |
Gründer | 21.01.2010 | 04.04.2012 | |
PFIZER, INC. | Corporate Officer/Principal | - | - |
STRYKER CORPORATION | Vertrieb & Marketing | - | - |
Ausbildung von Gregory Lambrecht
Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 7 |
Operativ
Founder | 3 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Non-Durables | 2 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PFIZER, INC. | Health Technology |
STRYKER CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Viacor, Inc.
![]() Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Health Technology |
Coravin, Inc.
![]() Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Consumer Non-Durables |
Intrinsic Therapeutics, Inc.
![]() Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Health Technology |
- Börse
- Insiders
- Gregory Lambrecht
- Erfahrung